Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?

European Journal of Endocrinology

Volumn 155, Issue 6, 2006, Pages 783-786

  Laurberg, Peter ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CARBIMAZOLE; LEVOTHYROXINE; PERCHLORATE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL STUDY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; EUTHYROIDISM; GRAVES DISEASE; HUMAN; IMMUNOREGULATION; LOW DRUG DOSE; META ANALYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REMISSION; SHORT SURVEY; SYSTEMATIC REVIEW; THYROID SURGERY; UNSPECIFIED SIDE EFFECT;

ANTITHYROID AGENTS; AUTOIMMUNITY; GRAVES DISEASE; HUMANS; REMISSION INDUCTION; THYROID GLAND;

EID: 33845972971     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02295     Document Type: Short Survey

References (21)

1. Codaccioni JL, Orgiazzi J, Blanc P, Pugeat M, Roulier R & Carayon P. Lasting remissions in patients treated for Graves' hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease. Journal of Clinical Endocrinology and Metabolism 1988 67 656-662.
2. Pinchera A, Liberti P, Martino E, Fenzi GF, Grasso L, Rovis L, Baschieri L & Doria G. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. Journal of Clinical Endocrinology and Metabolism 1969 29 231-238.
3. Schleusener H, Finke R, Kotulla P, Wenzel KW, Meinhold H & Roedler HD. Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease? Journal of Endocrinological Investigation 1978 1 155-161.
4. Fenzi GF, Hashizume K, Roudeboush CP & DeGroot LJ. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. Journal of Clinical Endocrinology and Metabolism 1979 48 706.
5. McGregor AM, Petersen MM, McLachlan SM, Rooke P, Smith BR & Hall R. Carbimazole and the autoimmune response in Graves' disease. New England Journal of Medicine 1980 7 302-307.
6. Docter R, Bos G, Visser TJ & Hennemann G. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator. Clinical Endocrinology 1980 12 143-153.
7. Bech K & Madsen SN. Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease. Clinical Endocrinology 1980 13 417.
8. Cooper DS. Antithyroid drugs. New England Journal of Medicine 2005 3 905-917.
9. Wenzel KW & Lente JR. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves' disease: evidence against an immunosuppressive action of thionamide drugs. Journal of Clinical Endocrinology and Metabolism 1984 58 62-69.
10. Volpé R. The pathogenesis of Graves' disease: an overview. Clinics in Endocrinology and Metabolism 1978 7 3-29.
11. Torring O, Tallstedt L, Wallin G, Lundell G, Ljunggren JG, Taube A, Saaf M & Hamberger B. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radio iodine - a prospective, randomized study. Journal of Clinical Endocrinology and Metabolism 1996 81 2986-2993.
12. Romaldini JH, Bromberg N, Werner RS, Tanaka LM, Rodrigues HF, Werner MC, Farah CS & Reis LC. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1983 57 563-570.
13. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M & Nagasawa T. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. New England Journal of Medicine 1991 4 947-953.
14. Abraham P, Avenell A, Park CM, Watson WA & Bevan JS. A systematic review of drug therapy for Graves' hyperthyroidism. European Journal of Endocrinology 2005 153 489-498.
15. Volpe R. The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyte-immunocyte signalling. Current Pharmaceutical Design 2001 7 451-460.
16. Bonnema SJ, Bartalena L, Toft AD & Hegedus L. Controversies in radioiodine therapy: relation to ophthalmopathy, the possible radioprotective effect of antithyroid drugs, and use in large goitres. European Journal of Endocrinology 2002 147 1-11.
17. Shizume K. Long term antithyroid drug therapy for intractable cases of Graves' disease. Endocrinologia Japonica 1978 25 377-379.
18. Slingerland DW & Burrows BA. Long-term antithyroid treatment in hyperthyroidism. Journal of the American Medical Association 1979 30 2408-2410.
19. Lippe BM, Landaw EM & Kaplan SA. Hyperthyroidism in children treated with long-term medical therapy: twenty-five percent remission every two years. Journal of Clinical Endocrinology and Metabolism 1987 64 1241-1245.
20. Azizi F, Ataie L, Hedayati M, Mehrabi Y & Sheikholeslami F. Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. European Journal of Endocrinology 2005 152 695-701.
21. Laurberg P, Andersen S & Karmisholt J. Antithyroid drug therapy of Graves' hyperthyroidism: realistic goals and focus on evidence. Expert Review of Endocrinology and Metabolism 2006 1 91-102.